CClinicalTrials.gg
CompletedNCT04921202Updated Jun 10, 2021

Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function

An observational study in Metabolic Syndrome, Meniscus Lesion and Obesity, Abdominal, sponsored by The First People's Hospital of Jingzhou. Completed at 1 site in China. Open to participants aged 35 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-10.

Sponsored by The First People's Hospital of Jingzhou · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
180
Ages
35 Years to 70 Years
Sex
All
01

Study summary

Studies have suggested that Obese patients with metabolic syndrome(MetS)were correlated with knee joint degeneration and osteoarthritis. However, no studies demonstrate the relationship between obese patients with metabolic syndrome and degenerate meniscus lesions and its knee function.The aim is to detect the correlation between obese patients with metabolic syndrome and degenerate meniscus injuries.

Read the detailed description

Obese patients with metabolic syndrome(MetS)were correlated with knee joint degeneration and osteoarthritis. However, no studies demonstrate the relationship between patients with metabolic syndrome and degenerate meniscus lesions or knee function. Participants were recruited from First Affiliated Hospital of Jinzhou Medical University. 100 BMI\<24 people without Metabolic syndrome volunteers aged between 35-70 years old and 80 Metabolic syndrome patients with BMI>27 were included in the study. Obese patients with MetS were assessed knee function and degenerate meniscus tears verified by magnetic resonance imaging. And patients with a mild or no osteoarthritis with Kellgren and Lawrence grade\<2 verified by X ray. We tested the relationship between metabolic syndrome and degenerate meniscus lesions. Obese patients with MetS and volunteers were detected by Mcmurry's test and MRI image to measure degeneration grade of meniscus tears. Number of MetS components were accounted and the knee function KOOS, IKDC score or degenerate meniscus tears were analyzed.

02

Conditions studied

  • Metabolic Syndrome
  • Meniscus Lesion
  • Obesity, Abdominal
  • Knee Arthritis

Keywords

  • Metabolic Syndrome
  • degenerate meniscus lesions
  • obesity
  • knee function
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 329 are open to participants now.

This study's enrollment of 180 is close to the median of 200 across 458 observational studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

The First People's Hospital of Jingzhou is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

participants from Jinzhou City, west of Liaoning Province

Inclusion criteria

  • Must be age between 35 and 70 years old;
  • Clinical diagnosis of metabolic syndrome;
  • BMI score more than 27 or less than 24
  • Clinical diagnosis of 3 grade degneration meniscus leisons;

Exclusion criteria

Exclusion Criteria:

  • Must be able to have no acute knee injury such as car crash or acute sports injury;
  • Must be able to have no knee surgeries history;
  • Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity;
  • Must be able to have no contraindications to MRI;
  • Must be able to have no severe cardiopulmonary disease;
  • Must be able to have no musculoskeletal or neuromuscular impairments ;
  • Must be able to have good visual, hearing, or cognitive;
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
180 participants (actual)
Patient registry
No

Groups and cohorts

  • without metabolic syndrome and BMI<24

    100 volunteers aged between 35-70 years old with body mass index(BMI)\<24 without Metabolic syndrome

  • Metabolic Syndrome with BMI>27

    80 Metabolic syndrome patients with BMI\>27 were included in the study

    Other: Metabolic syndrome and meniscus injuries

Interventions

  • OtherMetabolic syndrome and meniscus injuries

    Metabolic syndrome

06

What researchers measure

Primary outcomes

  1. the Knee injury and Osteoarthritis Outcome Score (KOOS) total

    The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems).

    Time frame: up to 12 month

  2. The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score

    The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score to determine the meniscus function. The IKDC is a questionnaire that has high reliability and validity for patients with a meniscal tear\[36, 37\] \[38\]. The questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.) The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst.

    Time frame: up to 12 month

Secondary outcomes

  1. KOOS Pain subscale

    Pain including 9 items,The minimum value is 0 and maximum values subscale is 100, the scored separately from zero (extreme knee problems) to 100 (no knee problems)

    Time frame: up to 12 month

  2. Symptoms subscale

    Symptoms including 7 items,The minimum value is 0 and maximum values subscale is 100. Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)

    Time frame: up to 12 month

  3. Activities of Daily Living subscale

    Activities of Daily Living including 17 items,The minimum value is 0 and maximum values subscale is100. Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems).

    Time frame: up to 12 month

  4. Sport and Recreation function subscale

    Sport and Recreation function including 5 items,The minimum value is 0 and maximum values subscale is 100. Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems).

    Time frame: up to 12 month

  5. knee-related Quality of Life subscale

    knee-related Quality of Life including 4 items,The minimum value is 0 and maximum values subscale is 100. Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems).

    Time frame: up to 12 month

  6. KOOS4

    KOOS4, The minimum value is 0 and maximum values subscale is100. KOOS4 defined as the average score for four of the five knee injury and osteoarthritis outcome score (KOOS) validity for patients with meniscal tears and osteoarthritis.

    Time frame: up to 12 month

07

Study locations

1 site
  • First Affiliated Hospital of Jinzhou Medical University
    Jinzhou, Liaoning 121000, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04921202
Lead sponsor
The First People's Hospital of Jingzhou
Responsible party
Hongyu Wang (chief residents, The First People's Hospital of Jingzhou) — Principal investigator
First posted
Jun 10, 2021
Start date
Jun 1, 2017
Primary completion
Mar 25, 2020
Completion
Mar 1, 2021
Last update
Jun 10, 2021

Study contacts

Hongyu Wang, Doctor
principal investigator · The First People's Hospital of Jingzhou

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion